Rifkin A
Department of Psychiatry, Albert Einstein College of Medicine, Bronx, New York.
Psychiatr Clin North Am. 1993 Jun;16(2):351-63.
One article is too short for a comprehensive discussion of drug treatment of schizophrenia. The most important features, many of which are controversial, have been emphasized. We await future research that will answer these questions, and will show us better and safer treatments. We must be sure to use our present treatments optimally, which means exerting extra effort to overcome continuing symptoms, even if it means trying many different drugs and even combinations of drugs.
一篇文章对于全面讨论精神分裂症的药物治疗来说篇幅太短。文中强调了最重要的一些特征，其中许多都存在争议。我们期待未来的研究能回答这些问题，并为我们展现出更好、更安全的治疗方法。我们必须确保以最佳方式使用目前的治疗方法，这意味着要付出额外努力来克服持续存在的症状，即便这意味着要尝试多种不同药物甚至药物组合。
